Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2015Breast Cancer Targets and TherapyOpen Access

Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factorbinding protein 3?

View Full Paper
Ask AI
Bookmark
Share

Authors

CPClaire M. PerksSouthmead HospitalHZHanna ZielińskaSouthmead HospitalJHJeff M.P. HollyUniversity of Bristol

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Perks et al. (2015) studied this question.

synapsesocial.com/papers/6a7228dc84cc45bb7be0127chttps://doi.org/10.2147/bctt.s43932
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and the Risk of Breast Cancer2007 · 97 citations
  2. 2IGF-1R as an anti-cancer target--trials and tribulations2013 · 204 citations
  3. 3Interaction of Insulin Receptor Substrate-2 (IRS-2) with the Insulin and Insulin-like Growth Factor I Receptors1996 · 137 citations
  4. 4Functional Cooperation between Snail1 and Twist in the Regulation of ZEB1 Expression during Epithelial to Mesenchymal Transition2011 · 353 citations
  5. 5CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer2011 · 69 citations